Alderson, S. L., Wright-Hughes, A., Ford, A. C., Farrin, A., Hartley, S., Fernandez, C., . . . Everitt, H. (2022). Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): Protocol for a randomised double-blind placebo-controlled trial in primary care. Current controlled trials in cardiovascular medicine, 23(1), 552-12. https://doi.org/10.1186/s13063-022-06492-6
Citace podle Chicago (17th ed.)Alderson, Sarah L., et al. "Amitriptyline at Low-dose and Titrated for Irritable Bowel Syndrome as Second-line Treatment (The ATLANTIS Trial): Protocol for a Randomised Double-blind Placebo-controlled Trial in Primary Care." Current Controlled Trials in Cardiovascular Medicine 23, no. 1 (2022): 552-12. https://doi.org/10.1186/s13063-022-06492-6.
Citace podle MLA (9th ed.)Alderson, Sarah L., et al. "Amitriptyline at Low-dose and Titrated for Irritable Bowel Syndrome as Second-line Treatment (The ATLANTIS Trial): Protocol for a Randomised Double-blind Placebo-controlled Trial in Primary Care." Current Controlled Trials in Cardiovascular Medicine, vol. 23, no. 1, 2022, pp. 552-12, https://doi.org/10.1186/s13063-022-06492-6.